logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Resistance To Immunotherapeutic Antibodies In Cancer Strategies To Overcome Resistance 1st Edition Lina Reslan

  • SKU: BELL-4319422
Resistance To Immunotherapeutic Antibodies In Cancer Strategies To Overcome Resistance 1st Edition Lina Reslan
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Resistance To Immunotherapeutic Antibodies In Cancer Strategies To Overcome Resistance 1st Edition Lina Reslan instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 4.05 MB
Pages: 202
Author: Lina Reslan, Charles Dumontet (auth.), Benjamin Bonavida (eds.)
ISBN: 9781461476535, 9781461476542, 1461476534, 1461476542
Language: English
Year: 2013
Edition: 1

Product desciption

Resistance To Immunotherapeutic Antibodies In Cancer Strategies To Overcome Resistance 1st Edition Lina Reslan by Lina Reslan, Charles Dumontet (auth.), Benjamin Bonavida (eds.) 9781461476535, 9781461476542, 1461476534, 1461476542 instant download after payment.

​​​​The traditional approaches to treat various cancers include chemotherapy, radiation and/or hormonal therapy. While these therapies continue to be effective in large part, they are not selective and highly toxic. There have been encouraging results in alternative therapeutic approach called antibody-mediated anti-cancer therapy, which is less toxic, more selective, and can also reverse drug/radiation resistance. Monoclonal antibodies or mAbs can be used to destroy malignant tumor cells and prevent tumor growth by blocking specific cell receptors. mAbs can bind only to cancer cell-specific antigens and induce an immunological response against the target cancer cell. The book covers the common and unique features of mAbs agains various cancer, gives the latest developments on the molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance.

Related Products